# Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers

> **NCT07731880** · — · RECRUITING · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Malignant Female Reproductive System Neoplasm
- Metastatic Malignant Female Reproductive System Neoplasm
- Unresectable Malignant Female Reproductive System Neoplasm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07731880
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2029-07
- **Final completion:** 2029-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07731880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07731880, "Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07731880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*